Breast Cancer
Conference Coverage
Twenty years and counting: Tamoxifen’s lasting improvement in breast cancer
Study suggests long-term improvement for some women with breast cancer.
Conference Coverage
Uninformed breast cancer patients are making treatment decisions
Clouded by the thought “I have breast cancer,” patients are making uninformed treatment decisions.
From the Journals
Breast cancer test recommended for extended endocrine therapy
The benefit of endocrine therapy after 5 years in early-stage, HR-positive breast cancer is questionable, but the Breast Cancer Index can help...
Diminutio
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
Conference Coverage
Misconceptions remain on gene signature use in breast cancer
The “misconception regarding the predictive value of these tests on chemotherapy benefits suggest there is still room for training on results...
Recap
Treating High-Risk, Early-Stage HR+/HER2- Breast Cancer
Dr Michelle Melisko discusses treatment for high-risk, early-stage HR+/HER2- breast cancer, including use of genomic assays, the...
Latest News
Low vitamin D tied to breast cancer risk in Hispanic women
“Few studies have examined the association between vitamin D and breast cancer within these racial/ethnic groups.”
Conference Coverage
Recurrent DCIS can be genetically distinct from primary lesion
Findings may change how breast cancer patients are treated.
From the Journals
Which breast cancer surgery leads to better quality of life?
Superior psychosocial and sexual well-being at 10 years after surgery was reported by women who underwent breast-conserving surgery and adjuvant...
Conference Coverage
1 in 7 breast cancer patients report worsening personal finances
New survey doesn’t find a link between money woes and stage of disease or treatment.
Conference Coverage
Omega-3 fatty acids linked to less FOXA1 in benign breast tissue
Findings suggest transcription factor could be a helpful biomarker in cancer prevention trials.